Explore & Discover Scientific Journals

Circulation is a scientific journal published by Lippincott Williams & Wilkins for the American Heart Association. The journal publishes articles related to research in and the practice of cardiovascular diseases, including observational studies, clinical trials, epidemiology, health services and outcomes studies, and advances in applied (translational) and basic research. From 1996 to 2004, its impact factor remained close to 10. As of 2012, its impact factor was 15.202 and it ranked first among journals in the Cardiac and Cardiovascular Systems, Peripheral Vascular Disease categories.

Circulation Research is a forum for fundamental, mechanistic research of relevance to the cardiovascular system from various disciplines including biochemistry, biophysics, cellular biology, molecular biology, genetics, pathology, physiology, and pharmacology. The journal publishes manuscripts of the highest quality pertaining to basic cardiac and vascular biology and encourages the submission of work that uses state-of-the-art approaches to illuminate mechanisms of human disease. A special welcome is extended to translational research and to clinical research that yields fundamental insights; studies in humans or human tissues that advance our understanding of the basis of disease and the mechanism of therapies are an area of particular emphasis.

Angiogenesis is an international peer-reviewed journal devoted to the publication of top quality original articles and reviews on the cellular and molecular mechanisms that regulate angiogenesis in physiological and pathological conditions. As a central source for rapid communications representing the full spectrum of angiogenesis research, this multidisciplinary journal publishes innovative experimental studies using molecular, in vitro, animal model systems and clinical investigations of angiogenic diseases. Angiogenesis also reports on novel therapeutic approaches for promoting or inhibiting angiogenesis as well as new markers and techniques for disease diagnosis and prognosis.

The Journal of Stroke (JoS) provides stroke clinicians and researchers with peer-reviewed articles on clinical and basic investigation of cerebral circulation and associated diseases to enhance patient management, education, clinical or experimental research, and professionalism. The jour-nal will consider submissions in areas including, but not limited to, the following: pathophysiology, risk factors, symptomatology, imaging, treatment, and rehabilitation of stroke. We have a particular interest in strokes in Asian populations as they have features distinct from strokes in the other part of the world. Clinical researches on intracranial atherosclerosis, small vessel diseases, hemorrhagic strokes, and relevant basic researches are welcome, as are issues in epidemiology, public education, and clinical practice guidelines in Asian countries.

JRAAS is a peer-reviewed, open access journal, serving as a resource for biomedical professionals, primarily with an active interest in the renin-angiotensin-aldosterone system in humans and other mammals. It publishes original research and reviews on the normal and abnormal function of this system and its pharmacology and therapeutics, mostly in a cardiovascular context but including research in all areas where this system is present, including the brain, lungs and gastro-intestinal tract.

Hypertension delivers some of the best high blood pressure-related articles in each monthly issue. Articles are focused on basic science, clinical treatment, and prevention of hypertension and related cardiovascular, metabolic and renal diseases, and are the papers which will prove their significance for years to come. Online subscriptions are available to members of the American Heart Association/American Stroke Association as a benefit of membership depending on membership level.

ATVB is the forum for publication of research on the biology, prevention, and impact of vascular diseases related to arteriosclerosis and thrombosis from a variety of disciplines including biochemistry, biophysics, cell and molecular biology, clinical investigation, epidemiology, genetics, lipoproteins, nutrition, metabolism, and pathology. Online subscriptions are available to members of the American Heart Association/American Stroke Association as a benefit of membership depending on membership level.

Atherosclerosis has an open access mirror journal Atherosclerosis: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review. Atherosclerosis brings together, from all sources, papers concerned with investigation on atherosclerosis, its risk factors and clinical manifestations. Atherosclerosis covers basic and translational, clinical and population research approaches to arterial and vascular biology and disease, as well as their risk factors including: disturbances of lipid and lipoprotein metabolism, diabetes and hypertension, thrombosis, and inflammation. The Editors are interested in original or review papers dealing with the pathogenesis, environmental, genetic and epigenetic basis, diagnosis or treatment of atherosclerosis and related diseases as well as their risk factors.

The International Journal of Stroke is a welcome addition to the international stroke journal landscape in that it concentrates on the clinical aspects of stroke with basic science contributions in areas of clinical interest. Reviews of current topics are broadly based to encompass not only recent advances of global interest but also those which may be more important in certain regions and the journal regularly features items of news interest from all parts of the world. To facilitate the international nature of the journal, our Associate Editors from Europe, Asia, North America and South America coordinate segments of the journal.

Serving as an international forum for the exchange of state-of-the-art scientific and clinical information on all aspects of human and animal hypertension, this authoritative journal publishes full articles as well as solicited and unsolicited reviews and commentaries that extend current understanding as well as facilitate the timely and successful detection, management, control, and prevention of hypertension-related conditions. Features special issues covering proceedings of symposia on hypertension research! Clinical and Experimental Hypertension maintains a rapid communications format that brings readers new and important research and findings in a prompt and reliable publication schedule in areas, including: antihypertensive agents circulatory control drug development and application etiology mechanisms of action neurogenic mechanisms pathophysiology pharmacological and nonpharmacological treatment and much more!

This journal intends to provide clear, insightful, balanced contributions by international experts that review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of hypertension. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as antihypertensive therapies, associated metabolic disorders, and therapeutic trials. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.

Clinical Hypertension is a leading international peer-reviewed journal publishing original research, clinical updates, and reviews indexed in Clarivate Web of Science (SCIE) with Q1 quartile ranking.

The Journal of Hypertension publishes papers reporting original clinical and experimental research which are of a high standard and which contribute to the advancement of knowledge in the field of hypertension. The Journal publishes full papers, reviews or editorials (normally by invitation), and correspondence.

The Journal of Thrombosis and Haemostasis (JTH) is the official journal of the International Society on Thrombosis and Haemostasis. The mission of JTH is to advance science related to the important medical problems of thrombosis, bleeding disorders and vascular biology through the diffusion and exchange of information and ideas within the international research community. The Journal publishes high quality, original research reports, state of the art reviews, brief reports, case reports, invited commentaries on publications in the Journal, forum articles, correspondence and announcements. Editors invite both fundamental and clinical contributions. These include basic manuscripts on blood coagulation and fibrinolysis, proteins and reactions, blood platelets, and the interaction of all these components with other biological systems such as, but not limited to, the vessel wall, blood cells, and invading organisms. Clinical manuscripts can cover a wide variety of topics including venous thrombosis and arterial disease, plus hemophilia and other bleeding disorders, as well as platelet diseases. The subject area of clinical manuscripts can range from etiology to diagnostics, prognosis, prevention, and treatment.

Thrombosis and Haemostasis publishes reports on basic, translational and clinical research dedicated to novel results and highest quality in any area of thrombosis and haemostasis, vascular biology and medicine, inflammation and infection, platelet and leukocyte biology, from genetic, molecular & cellular studies, diagnostic, therapeutic & preventative studies to high-level translational and clinical research. The journal provides position and guideline papers, state-of-the-art papers, expert analysis and commentaries, and dedicated theme issues covering recent developments and key topics in the field.

Hypertension Research is the official publication of the Japanese Society of Hypertension. The journal publishes papers reporting original clinical and experimental research that contribute to the advancement of knowledge in the field of hypertension and related cardiovascular diseases. The journal publishes Review Articles, Articles, Correspondence and Comments. Manuscripts submitted to Hypertension Research will be accepted on the understanding that the author must not have previously submitted the paper to another journal or have published the material elsewhere.

Seminars in Thrombosis and Hemostasis is a topic driven review journal that focuses on all issues relating to hemostatic and thrombotic disorders. As one of the premiere review journals in the field, Seminars in Thrombosis and Hemostasis serves as a comprehensive forum for important advances in clinical and laboratory diagnosis and therapeutic interventions. The journal also publishes peer reviewed original research papers. Seminars offers an informed perspective on today's pivotal issues, including hemophilia A & B, thrombophilia, gene therapy, venous and arterial thrombosis, von Willebrand disease, vascular disorders and thromboembolic diseases. Attention is also given to the latest developments in pharmaceutical drugs along with treatment and current management techniques. The journal also frequently publishes sponsored supplements to further highlight emerging trends in the field.

JAT publishes articles focused on all aspects of research on atherosclerosis, vascular biology, thrombosis, lipid and metabolism.

Thrombosis Research is an international journal with a goal of rapid dissemination of new information on thrombosis, hemostasis, and vascular biology to advance science and clinical care. The journal publishes peer-reviewed original research, along with reviews, editorials, and opinions and critics. Both basic and clinical studies are published. Publication of research which will lead to novel approaches in diagnosis, therapy, prognosis and prevention of thrombotic and hemorrhagic diseases is given high priority.

Vasa is the European journal of vascular medicine. It is the official organ of the German, Swiss, and Slovenian Societies of Angiology. The journal publishes original research articles, case reports and reviews on vascular biology, epidemiology, prevention, diagnosis, medical treatment and interventions for diseases of the arterial circulation, in the field of phlebology and lymphology including the microcirculation, except the cardiac circulation. Vasa combines basic science with clinical medicine making it relevant to all physicians interested in the whole vascular field.